Exane Derivatives’s Telus TU Stock Holding History

Exane Derivatives’s Portfolio TU Stock Details TU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-18,000	Closed	-$314K	–	703
2018 Q1	$314K	Buy	+18,000	New	+$329K	0.06%	189

Other funds holding TU

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return

Exane Derivatives's TU Position: Q2 2018 in Review

Exane Derivatives sold out of Telus (TU) in Q2 2018, closing a stake of 18,000 shares — an estimated $314K sold.

Exane Derivatives first reported a position in TU in Q1 2018 and held it in 1 quarter. The position peaked at $314K in Q1 2018. 251 funds tracked by Wall St. Rank hold TU as of Q2 2018.

Exane Derivatives reported no remaining Telus position as of Q2 2018 after selling out during the quarter.
Exane Derivatives sold 18,000 Telus shares in Q2 2018, an estimated $314K.
Exane Derivatives first reported a position in Telus in Q1 2018 and held it in 1 quarter.
Exane Derivatives's Telus position peaked at $314K in Q1 2018.
251 funds tracked by Wall St. Rank held Telus as of Q2 2018.

Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.